Evidence map›Paper›PMID 28677221›Full record

ArticleHuman mutation2017

Characterization of cryptic splicing in germline PTEN intronic variants in Cowden syndrome.

Hannah Jinlian Chen, Todd Romigh, Kaitlin Sesock, Charis Eng

Open access · hybridAbstract read
In one paragraph

Article in Human mutation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Cowden Syndrome and Oral Lesions: A Case Report Using MLPA.The American journal of case reports · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Rare Hereditary Gynecological Cancer Syndromes.International journal of molecular sciences · 2022
    Review
  12. Article
  13. Review
  14. Article
  15. Frontiers in medicine · 2021
    Article
  16. Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2020
    Article
  17. The Complex Landscape ofCold Spring Harbor perspectives in medicine · 2020
    Review
  18. PTEN in Hereditary and Sporadic Cancer.Cold Spring Harbor perspectives in medicine · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hannah Jinlian ChenGenomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio.
Todd RomighGenomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio.
Kaitlin SesockGenomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio.
Charis EngGenomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0002-3693-5145
Cleveland Clinic · US

Funding

Selective Modulation of Thyroidal RadioiodineP01CA124570 · NCI · OHIO STATE UNIVERSITY · PI RINGEL, MATTHEW D · 2008 to 2017
$23.4M
PTEN Nuclear-Cytoplasmic Localization in Breast CancerR01CA118980 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI ENG, CHARIS · 2007 to 2011
$1.8M
Deep Sequencing Instrumentation Upgrade - Illumina HiSeq2500S10OD018058 · OD · CLEVELAND CLINIC LERNER COM-CWRU · PI ENG, CHARIS · 2014 to 2014
$600k
NCI NIH HHS P01 CA124570NCI NIH HHS R01 CA118980NIH HHS S10 OD018058
6 · The paper itself

Abstract

Germline mutations in the tumor-suppressor gene PTEN predispose to subsets of Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome, and autism. Evidence-based classification of PTEN variants as either deleterious or benign is urgently needed for accurate molecular diagnosis and gene-informed genetic counseling. We studied 34 different germline PTEN intronic variants from 61 CS patients, characterized their PTEN mRNA processing, and analyzed PTEN expression and downstream readouts of P-AKT and P-ERK1/2. While we found that many mutations near splice junctions result in exon skipping, we also identified the presence of cryptic splicing that resulted in premature termination or a shift in isoform usage. PTEN protein expression is significantly lower in the group with splicing changes while P-AKT, but not P-ERK1/2, is significantly increased. Our observations of these PTEN intronic variants should contribute to the determination of pathogenicity of PTEN intronic variants and aid in genetic counseling.

Indexed as

Pathology, MolecularAdolescentAdultAgedAlternative SplicingChildChild, PreschoolFemaleGene Expression RegulationGerm-Line MutationHamartoma Syndrome, MultipleHumansMaleMAP Kinase Signaling SystemMiddle AgedProtein IsoformsProtein IsoformsProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePTEN protein, humanRNA Splice Sitesalternative splicingBRRSCowden syndromecryptic splice sitesexon skippingmutationPTENtranscription isoform

Identifiers

PMID28677221
PMCPMC5599331
OpenAlexW2727730556

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.